Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thorax

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2009.123422PMID 20522854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening

  2009cited by this paper
• A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

  2009cited by this paper
• Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis

  2009cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

  2008cited by this paper
• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

  2008cited by this paper
• Implementation of the French nationwide cystic fibrosis newborn screening program.

  2008cited by this paper
• Nasal potential difference in cystic fibrosis diagnosis of very young children.

  2007cited by this paper
• A survey of newborn screening for cystic fibrosis in Europe.

  2007cited by this paper
• Early Pulmonary Manifestation of Cystic Fibrosis in Children With the ΔF508/R117H-7T Genotype

  2006cited by this paper
• The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening

  2006cited by this paper
• Cystic fibrosis: terminology and diagnostic algorithms

  2005cited by this paper
• Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.

  2005cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.

  2005cited by this paper
• Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis

  2004cited by this paper
• Genomic rearrangements in the CFTR gene: Extensive allelic heterogeneity and diverse mutational mechanisms

  2004cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.

  2003cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

  2003cited by this paper
• Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis.

  2002cited by this paper
• Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

  2001cited by this paper
• Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling

  2001cited by this paper
• A modified technique for measurement of nasal transepithelial potential difference in infants.

  2001cited by this paper
• Nasal potential difference measurements in patients with atypical cystic fibrosis.

  2001influential reference
• Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinaemia with normal sweat test

  2001cited by this paper
• The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

  1998cited by this paper
• In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis

  1995cited by this paper
• Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.

  1992cited by this paper

• Nasal Potential Difference in Young Children is Feasible - Report from a National Referral Center.

  2025cites this paper
• Cystic Fibrosis Newborn Screening.

  2025cites this paper
• Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically

  2024cites this paper
• Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years

  2023cites this paper
• Assessing accuracy of testing and diagnosis in cystic fibrosis

  2023cites this paper
• Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management.

  2023cites this paper
• Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient

  2023cites this paper
• ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction.

  2022cites this paper
• Assays of CFTR Function In Vitro, Ex Vivo and In Vivo

  2022cites this paper
• Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test

  2022cites this paper
• Insight into clinical, laboratory, and GIT ultrasound diagnostic findings of cystic fibrosis in pediatrics

  2022cites this paper
• Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward.

  2021cites this paper
• Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.

  2020cites this paper
• Diagnosis of Cystic Fibrosis

  2020cites this paper
• Gene Therapy for Respiratory Diseases: Progress and a Changing Context

  2020cites this paper
• Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis

  2020cites this paper
• Cystic Fibrosis Diagnosis in Newborns, Children, and Adults

  2019cites this paper
• Insights into the variability of nasal potential difference, a biomarker of CFTR activity.

  2019cites this paper
• Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

  2018cites this paper
• Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung

  2018cites this paper
• Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients

  2018cites this paper
• [Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].

  2017cites this paper
• Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening

  2017influential citation
• Diagnosis of Cystic Fibrosis in Screened Populations

  2017cites this paper
• Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening.

  2017cites this paper
• The diagnosis of cystic fibrosis.

  2017cites this paper
• Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned

  2017cites this paper
• Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

  2017cites this paper
• A sequence upstream of canonical PDZ-binding motif within CFTR COOH-terminus enhances NHERF1 interaction.

  2016cites this paper
• Cystic Fibrosis Diagnosis and Newborn Screening.

  2016cites this paper
• Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?

  2016cites this paper
• Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment.

  2016cites this paper
• Outcomes of Infants With Indeterminate Diagnosis Detected by Cystic Fibrosis Newborn Screening

  2015cites this paper
• Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population

  2015cites this paper
• Test de la sueur

  2015cites this paper
• Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice

  2013cites this paper
• Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain

  2013cites this paper
• Stimulation de cellules épithéliales bronchiques humaines par la GnRH : effet sur le transport ionique médié par le CFTR

  2013cites this paper
• Measurements of CFTR-Mediated Cl− Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis

  2012cites this paper
• Correction of the ion transport defect in Cystic Fibrosis by small molecules

  2012cites this paper
• Newborn screening for cystic fibrosis

  2012cites this paper
• CFTR biomarkers: time for promotion to surrogate end-point

  2012cites this paper
• Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect.

  2012cites this paper
• Utilisation des bactériophages comme thérapie lors d'une infection à Pseudomonas aeruginosa dans le cadre de la mucoviscidose : efficacité et innocuité

  2012cites this paper
• Prevalência de baixa densidade mineral óssea e fatores associados em pacientes adolescentes e adultos com fibrose cística

  2012cites this paper
• Chapter 2 – Development of the lungs; perinatal and developmental lung disease

  2011cites this paper
• Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome

  2011cites this paper
• [Newborn screening for cystic fibrosis, a clinical geneticist perspective].

  2011cites this paper
• Cystic fibrosis, primary ciliary dyskinesia and non-cystic fibrosis bronchiectasis: update 2008–11

  2011cites this paper
• [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].

  2010cites this paper
• Recommandations francaises pour la realisation et l'interpretation du test de la sueur dans le cadre du depistage neonatal de la mucoviscidose

  2010cites this paper
• Cystic fibrosis , primary ciliary dyskinesia and non-cystic fibrosis bronchiectasis : update 2008 e 11 W G Flight , 1 , 2

  year unknowncites this paper